TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,370.00
+15.00 (0.34%)
At close: Sep 4, 2026

TiumBio Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
14,99712,2896,7924,8999,11856.8
Revenue Growth
104.49%80.92%38.65%-46.27%15952.75%-94.58%
Gross Profit
5,9235,0441,9484,8999,11856.8
Operating Income
-16,082-16,139-18,699-27,832-25,640-32,696
Net Income
-17,111-17,360-20,644-17,911-29,853-31,637
Earnings Per Share
-600.80-640.37-799.00-734.27-1246.00-1329.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
32,80042,39150,62440,45735,10040,635
Total Debt
28,56132,15330,18029,00023,21119,474
Net Cash (Debt)
4,23910,23820,44411,45711,88921,161
Net Cash Growth
-70.12%-49.92%78.44%-3.63%-43.82%-68.57%
Net Cash Per Share
148.82377.64791.29469.70496.13888.58

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14,814-15,303-15,628-20,616-16,013-24,802
Capital Expenditures
-880.35-264.34-1,040-18,336-11,185-11,845
Free Cash Flow
-15,695-15,567-16,668-38,952-27,198-36,647
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.49%41.05%28.68%100.00%100.00%100.00%
Operating Margin
-107.23%-131.33%-275.30%-568.14%-281.22%-57566.15%
Pretax Margin
-122.72%-152.88%-346.67%-388.62%-344.42%-56785.56%
Profit Margin
-114.10%-141.27%-303.93%-365.62%-327.42%-55701.69%
FCF Margin
-104.65%-126.68%-245.40%-795.14%-298.31%-64522.48%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
8.7513.8816.5549.1133.198127.16